Tautvydas Valatka
๐Ÿงญ ๐Œ๐ฒ ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐ข๐ง๐  ๐‰๐จ๐ฎ๐ซ๐ง๐ž๐ฒ โ€“ ๐–๐ž๐ž๐ค ๐Ÿ”๐Ÿ This week was far from easy โ€” my portfolio declined, along with the U.S., European, and to a lesser extent, U.K. markets. Investor sentiment was weighed down by weaker-than-expected earnings from several major tech companies, growing concerns about a potential slowdown in economic growth, and uncertainty around the next central bank decisions on interest rates. Geopolitical tensions and profit-taking after the strong rally in recent months also added pressure. My weekly result: -2.69%, while the main indices also moved lower: ๐Ÿ‡บ๐Ÿ‡ธ $SPX500 : -1.63% ๐Ÿ‡ช๐Ÿ‡บ $EUSTX50 : -1.79% ๐Ÿ‡ฌ๐Ÿ‡ง $UK100 : -0.36% My portfolio followed a similar pattern to last week โ€” although just over half of the positions (13 out of 25) ended in the red, the declines were noticeably deeper than the gains. Four positions fell by more than 10%, several others came close, and the best performer rose only 4.69%. Weeks like this are never pleasant, but theyโ€™re a natural part of investing. After nearly 40% annual growth earlier this year, some correction is both inevitable and healthy โ€” it allows the market to cool off and return to a more sustainable pace of growth. The eToro Popular Investor program metrics remain solid, even in a week like this. The total value of copied assets decreased slightly to $94.6K (around $4.5K lower than the previous week), while the number of copiers stayed stable at 100. Looking at the bigger picture, the long-term results remain very encouraging: ๐Ÿ”น 2025 return: +32.2% โ€” still more than double the average of the tracked markets (+15.7%). ๐Ÿ”น Since strategy launch: +48.5% โ€” roughly three times above market average (+15.6%). Top weekly movers: ๐Ÿ”ป $GILT (Gilat Satellite Networks Ltd) : -14.42% ๐Ÿ”ป $HEIJM.NV (Koninklijke Heijmans NV) : -11.71% ๐Ÿ”ป $SSRM (SSR Mining Inc) : -11.61% ๐Ÿ”ป $PLTR (Palantir Technologies Inc.) : -11.24% ๐Ÿ”ป $6990.HK (Sichuan Kelun Biotech Biopharmaceutical Co Ltd): -8.71%